Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Metra

Showing results (61-70 of 1,326) with videos related to

Pageof 133
Sort By:
Obesity (Silver Spring, Md.)|July 28, 2016
Corrigendum: Carnosine: Potential aid for diabetes and cardiovascular diseaseCarlo Lombardi, Marco Metra
European Journal of Heart Failure|April 29, 2020
Corrigendum to 'Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015' [Eur J Heart Fail 2019;21:1329-1337]Marco Metra, Paola Lucioli
European Journal of Heart Failure|September 26, 2022
Morphine in acute pulmonary oedema: a signal of harm but more questions than answersOvidiu Chioncel, Marco Metra
European Journal of Heart Failure|August 5, 2021
Cardiogenic shock centres for optimal care coordination and improving outcomes in cardiogenic shockOvidiu Chioncel, Marco Metra
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2021
Treatment of secondary mitral regurgitation in patients with heart failure: when left ventricular ejection fraction may become not crucialMarco Metra, Marianna Adamo
JACC. Heart Failure|June 29, 2019
GENETIC-AF: Digging Deeper Into Genotype-Phenotype and Heart Failure-Atrial Fibrillation InteractionsPalak Shah, Marco Metra
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Worsening tricuspid regurgitation following a successful mitral valve procedure: how to manageFrancesco Maisano, Marco Metra
Giornale Italiano Di Cardiologia (2006)|March 2, 2019
[The COMMANDER-HF trial]Elisabetta Dinatolo, Marco Metra
European Journal of Heart Failure|October 16, 2021
Can mild to moderate secondary mitral regurgitation be a therapeutic target for symptomatic patients with heart failure with reduced ejection fraction?Marianna Adamo, Marco Metra
Lancet (London, England)|May 3, 2017
Heart failureMarco Metra, John R Teerlink
Pageof 133

Showing results (61-70 of 1,326) with videos related to

Sort By:
Pageof 133
Obesity (Silver Spring, Md.)|July 28, 2016
Corrigendum: Carnosine: Potential aid for diabetes and cardiovascular diseaseCarlo Lombardi, Marco Metra
European Journal of Heart Failure|April 29, 2020
Corrigendum to 'Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015' [Eur J Heart Fail 2019;21:1329-1337]Marco Metra, Paola Lucioli
European Journal of Heart Failure|September 26, 2022
Morphine in acute pulmonary oedema: a signal of harm but more questions than answersOvidiu Chioncel, Marco Metra
European Journal of Heart Failure|August 5, 2021
Cardiogenic shock centres for optimal care coordination and improving outcomes in cardiogenic shockOvidiu Chioncel, Marco Metra
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2021
Treatment of secondary mitral regurgitation in patients with heart failure: when left ventricular ejection fraction may become not crucialMarco Metra, Marianna Adamo
JACC. Heart Failure|June 29, 2019
GENETIC-AF: Digging Deeper Into Genotype-Phenotype and Heart Failure-Atrial Fibrillation InteractionsPalak Shah, Marco Metra
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
Worsening tricuspid regurgitation following a successful mitral valve procedure: how to manageFrancesco Maisano, Marco Metra
Giornale Italiano Di Cardiologia (2006)|March 2, 2019
[The COMMANDER-HF trial]Elisabetta Dinatolo, Marco Metra
European Journal of Heart Failure|October 16, 2021
Can mild to moderate secondary mitral regurgitation be a therapeutic target for symptomatic patients with heart failure with reduced ejection fraction?Marianna Adamo, Marco Metra
Lancet (London, England)|May 3, 2017
Heart failureMarco Metra, John R Teerlink
Pageof 133